NOD1 and fetal growth restriction: Furthermore, administration of FK565 induces a higher expression level of NOD1 in fetal vascular tissues and at the maternal–fetal interface, which result in intrauterine fetal growth restriction (IUGR) and death in pregnant mice [37].